| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |